FTO and gastric cancer: Ge et al. also innovatively proposed the detection of m6A levels in peripheral blood RNA as a potential reliable biomarker for GC diagnosis and follow-up and found that an increased peripheral blood m6A levels in patients with GC was accompanied by downregulation of the demethylases ALKBH5 and FTO [58].